BDBM99209 US8501708, 33

SMILES COc1cccc(CO[C@@H]2CCCC2Nc2ncnc3n(cnc23)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1

InChI Key InChIKey=DKXQAUQBUSRNHS-UHFFFAOYSA-N

Data  3 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 99209   

TargetAdenosine receptor A1(Rabbit)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99209(US8501708, 33)
Affinity DataKi:  5.59nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2013
Entry Details
Go to US Patent

TargetAdenosine receptor A3(Rabbit)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99209(US8501708, 33)
Affinity DataKi:  551nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2013
Entry Details
Go to US Patent

TargetAdenosine receptor A2(Rabbit)
Inotek Pharmaceuticals

US Patent
LigandPNGBDBM99209(US8501708, 33)
Affinity DataKi:  2.77E+3nMAssay Description:The compounds were studied in binding assays to determine selectivity and potency to A1, A2a and A3 adenosine receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2013
Entry Details
Go to US Patent